Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Addictions, Drug & Alcohol Institute, University of Washington, Seattle, Washington, USA.
Cannabis Cannabinoid Res. 2022 Aug;7(4):508-515. doi: 10.1089/can.2020.0165. Epub 2021 Apr 26.
Medical cannabis (marijuana) use is legal in 33 U.S. states and the District of Columbia. Clinicians can play an important role in helping patients access and weigh potential benefits and risks of medicinal cannabis. Accordingly, this study aimed to assess clinician beliefs and practices related to cannabis. Data are from 1506 family practice doctors, internists, nurse practitioners, and oncologists who responded to the 2018 DocStyles, a web-based panel survey of clinicians. Questions assessed medicinal uses for and practices related to cannabis and assessed clinicians' knowledge of cannabis legality in their state. Logistic regression was used to assess multivariable correlates of asking about, assessing, and recommending cannabis. Over two-thirds (68.9%) of clinicians surveyed believe that cannabis has medicinal uses and just over a quarter (26.6%) had ever recommended cannabis to a patient. Clinicians who believed cannabis had medicinal uses had 5.9 times the adjusted odds (95% confidence interval 3.9-8.9) of recommending cannabis to patients. Beliefs about conditions for medical cannabis use did not necessarily align with the current scientific evidence. Nearly two-thirds (60.0%) of clinicians surveyed incorrectly reported the legal status of cannabis in their state. Findings suggest that while clinicians believe that cannabis has medicinal uses, they may not have a full understanding of the scientific evidence and may not accurately understand their state-based policies for cannabis legalization and use. Given that clinicians are responsible for recommending medicinal cannabis in most states that have legalized it, ongoing education about the health effects of cannabis is warranted.
医用大麻(大麻)在美国 33 个州和哥伦比亚特区合法使用。临床医生可以在帮助患者了解和权衡药用大麻的潜在益处和风险方面发挥重要作用。因此,本研究旨在评估临床医生与大麻相关的信念和实践。数据来自 1506 名家庭医生、内科医生、执业护士和肿瘤学家,他们对 2018 年 DocStyles 做出了回应,这是一项针对临床医生的基于网络的小组调查。问题评估了大麻的药用用途和相关实践,并评估了临床医生对其所在州大麻合法性的了解。使用逻辑回归评估了询问、评估和推荐大麻的多变量相关性。超过三分之二(68.9%)接受调查的临床医生认为大麻具有药用价值,超过四分之一(26.6%)曾向患者推荐过大麻。认为大麻具有药用价值的临床医生推荐大麻给患者的调整后几率是 5.9 倍(95%置信区间 3.9-8.9)。对医用大麻使用条件的看法不一定与当前的科学证据相符。近三分之二(60.0%)接受调查的临床医生错误地报告了他们所在州大麻的合法地位。研究结果表明,尽管临床医生认为大麻具有药用价值,但他们可能对科学证据没有充分的了解,也可能无法准确了解其所在州的大麻合法化和使用政策。鉴于在大多数已合法化医用大麻的州,临床医生负责推荐医用大麻,因此有必要对大麻的健康影响进行持续教育。